Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
European phase III milnacipran monotherapy study in fibromyalgia syndrome
2006-001230-41Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of milnacipran in fibromyalgia (FM), sponsored by Pierre Fabre Laboratories. Primary endpoint: Long-term safety of milnacipran. Started Jul 2006; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2006-001230-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001230-41.